A Comparison of Ktrans Measurements Obtained with Conventional and First Pass Pharmacokinetic Models in Human Gliomas

Journal of Magnetic Resonance Imaging

Volumn 19, Issue 5, 2004, Pages 527-536

  Haroon, Hamied A ^a   Buckley, David L ^a   Patankar, Tufail A ^a   Dow, Graham R ^b   Rutherford, Scott A ^b   Balériaux, Danielle ^c   Jackson, Alan ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c ERASME HOSPITAL   (Belgium)

Author keywords

Blood volume; Brain; Dynamic contrast enhanced MRI; Glioma; Microvascular endothelial permeability; Perfusion; Pharmacokinetic modeling

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIFFUSION WEIGHTED IMAGING; DRUG DISTRIBUTION; FEMALE; FIRST PASS METHOD; GLIOMA; HUMAN; MALE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS; PRIORITY JOURNAL; TUMOR VOLUME; VASCULAR TISSUE; VOLUME TRANSFER CONSTANT MEASUREMENT; BIOLOGICAL MODEL; BLOOD VOLUME; BRAIN CIRCULATION; BRAIN TUMOR; CAPILLARY PERMEABILITY; COMPARATIVE STUDY; FEASIBILITY STUDY; IMAGE ENHANCEMENT; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; SENSITIVITY AND SPECIFICITY; VASCULARIZATION;

ADULT; AGED; BLOOD VOLUME; BRAIN NEOPLASMS; CAPILLARY PERMEABILITY; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; GLIOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; SENSITIVITY AND SPECIFICITY;

EID: 2442442764     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.20045     Document Type: Article

References (22)

1. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002;29:15-18.
2. Yamagishi S, Okamoto T, Amano S, Inagaki Y. Can we identify novel angiogenesis inhibitors from cultured embryonic cells? Med Hypotheses 2003;60:389-390.
3. Behzadian MA, Windsor LJ, Ghaly N, Liou G, Tsai NT, Caldwell RB. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J 2003;17:752-754.
4. Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review. Eur Rev Med Pharmacol Sci 1997;1:17-25.
5. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
6. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:621-628.
7. Larsson HB, Stubgaard M, Frederiksen JL, Jensen M, Henriksen O, Paulson OB. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 1990;16:117-131.
8. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17:357-367.
9. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
10. 2 contrast-enhanced dynamic MR imaging. J Magn Reson Imaging 2000;11:575-585.
11. Li KL, Zhu XP, Waterton J, Jackson A. Improved 3D quantitative mapping of blood volume and endothelial permeability in brain tumors. J Magn Reson Imaging 2000;12:347-357.
12. Buckley DL. Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 2002;47:601-606.
13. Weinmann HJ, Laniado M, Mutzel W. Pharmacokinetics of Gd-DTPA/ dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
14. Li KL, Zhu XP, Waterton JC, et al. Improving estimates of endothelial permeability surface area product using constrained fitting parameters for the estimation of the plasma tracer concentration function (PTCF). In: Proceedings of the 8th Annual Meeting of ISMRM, Denver, Colorado, USA, 2000. p 1968.
15. Fritz-Hansen T, Rostrup E, Larsson HB, Sondergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-231.
16. Parker GJ, Suckling J, Tanner SF, et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics. J Magn Reson Imaging 1997;7:564-574.
17. Li KL, Jackson A. New hybrid technique for accurate and reproducible quantitation of dynamic contrast-enhanced MRI data. Magn Reson Med 2003;50:1286-1295.
18. St Lawrence KS, Lee TY. An adiabatic approximation to the tissue homogeneity model for water exchange in the brain: I. Theoretical derivation. J Cereb Blood Flow Metab 1998;18:1365-1377.
19. Jayson GC, Zweit J, Jackson A, et al. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst 2002;94:1484-1493.
20. Jackson A, Haroon H, Zhu XP, Li KL, Thacker NA, Jayson G. Breath-hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first-pass leakage profile model. NMR Biomed 2002;15:164-173.
21. Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39-50.
22. Jackson A, Jayson GC, Li KL, et al. Reproducibility of quantitative dynamic contrast enhanced MRI in newly presenting gliomas. Br J Radiol 2003;76:153-162.